- Home
- STIM vs AVTE Comparison
STIM vs AVTE Comparison
Compare STIM & AVTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STIM
- AVTE
- Stock Information
- Founded
- STIM 2003
- AVTE 2018
- Country
- STIM United States
- AVTE United States
- Employees
- STIM N/A
- AVTE N/A
- Industry
- STIM Medical/Dental Instruments
- AVTE Biotechnology: Pharmaceutical Preparations
- Sector
- STIM Health Care
- AVTE Health Care
- Exchange
- STIM Nasdaq
- AVTE Nasdaq
- Market Cap
- STIM 83.5M
- AVTE 74.6M
- IPO Year
- STIM 2018
- AVTE 2021
- Fundamental
- Price
- STIM $2.35
- AVTE $2.54
- Analyst Decision
- STIM Buy
- AVTE Hold
- Analyst Count
- STIM 4
- AVTE 7
- Target Price
- STIM $4.67
- AVTE $11.75
- AVG Volume (30 Days)
- STIM 900.5K
- AVTE 262.6K
- Earning Date
- STIM 03-04-2025
- AVTE 11-12-2024
- Dividend Yield
- STIM N/A
- AVTE N/A
- EPS Growth
- STIM N/A
- AVTE N/A
- EPS
- STIM N/A
- AVTE N/A
- Revenue
- STIM $72,711,000.00
- AVTE N/A
- Revenue This Year
- STIM $1.97
- AVTE N/A
- Revenue Next Year
- STIM $7.96
- AVTE N/A
- P/E Ratio
- STIM N/A
- AVTE N/A
- Revenue Growth
- STIM 5.03
- AVTE N/A
- 52 Week Low
- STIM $0.52
- AVTE $1.25
- 52 Week High
- STIM $5.07
- AVTE $32.42
- Technical
- Relative Strength Index (RSI)
- STIM 67.03
- AVTE 40.60
- Support Level
- STIM $2.18
- AVTE $2.40
- Resistance Level
- STIM $2.65
- AVTE $2.60
- Average True Range (ATR)
- STIM 0.29
- AVTE 0.09
- MACD
- STIM 0.04
- AVTE -0.01
- Stochastic Oscillator
- STIM 65.69
- AVTE 18.18
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
About AVTE Aerovate Therapeutics Inc.
Aerovate Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare cardiopulmonary disease. The initial focus of the company is on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension.